Myeloperoxidase: A New Biomarker of Inflammation in Ischemic Heart Disease and Acute Coronary Syndromes

Essick, E. E., & Sam, F. (2011). Cardiac Hypertrophy and Fibrosis in the Metabolic Syndrome: A Role for Aldosterone and the Mineralocorticoid Receptor. International Journal of Hypertension, 2011(), 307-318. https://doi.org/10.4061/2011/346985
Blancke, F., Claeys, M. J., Jorens, P., Vermeiren, G., Bosmans, J., Wuyts, F. L., & Vrints, C. J. (2005). Systemic Inflammation and Reperfusion Injury in Patients With Acute Myocardial Infarction. Mediators of Inflammation, 2005(), 385-389. https://doi.org/10.1155/MI.2005.385
Hsieh, C. Y. (2020). The Role of Biomarkers Derived from Adipocyte Inflammation in Metabolic Health and End-stage Renal Disease [doctoral dissertation, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU202003468
Lobbes, M. B. I., Kooi, M. E., Lutgens, E., Ruiters, A. W., Passos, V. L., Braat, S. H. J. G., Rousch, M., Cate, H. T., Engelshoven, J. M. A. V., Daemen, M. J. A. P., & Heeneman, S. (2010). Leukocyte Counts, Myeloperoxidase, and Pregnancy-Associated Plasma Protein A as Biomarkers for Cardiovascular Disease: Towards a Multi-Biomarker Approach. International Journal of Vascular Medicine, 2010(), 48-56. https://doi.org/10.1155/2010/726207
Delporte, C., Antwerpen, P. V., Vanhamme, L., Roumeguère, T., & Boudjeltia, K. Z. (2013). Low-Density Lipoprotein Modified by Myeloperoxidase in Inflammatory Pathways and Clinical Studies. Mediators of Inflammation, 2013(), 569-586. https://doi.org/10.1155/2013/971579